Skip to main content
MedinCell S.A. logo

MedinCell S.A. — Investor Relations & Filings

Ticker · MEDCL ISIN · FR0004065605 LEI · 969500R79U6PXCL2FF46 PA Manufacturing
Open in API
Filings indexed 522 across all filing types
Latest filing 2020-09-11 AGM Information
Country FR France
Listing PA MEDCL

About MedinCell S.A.

https://www.medincell.com/en/

MedinCell S.A. is a pharmaceutical company at the commercial stage that specializes in the development of long-acting injectable (LAI) therapies. The company's core is its proprietary BEPO® technology platform, which enables the controlled and sustained release of active pharmaceutical ingredients over periods ranging from days to months after a single injection. This technology forms a fully biodegradable depot in situ, designed to improve treatment efficiency, enhance patient compliance, and increase the global accessibility of medicines. MedinCell develops a portfolio of LAI products across various therapeutic areas, including psychiatry, advancing its pipeline through both internal research and strategic partnerships with other pharmaceutical organizations.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
AGM Information Classification · 99% confidence The document explicitly states that MedinCell released the results of its 'ordinary annual and extraordinary general meeting of shareholders' held on September 10, 2020. It details which resolutions were approved and mentions that the full details on the vote results will be available soon. This content directly relates to the proceedings and outcomes of an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R). It is not a DVA (Declaration of Voting Results) because it is an announcement *about* the meeting and the results, not the final, detailed official vote tally itself, although it is closely related. Given the title and content focus on the meeting itself, AGM-R is the best fit.
2020-09-11 English
Informations privilégiées / Autres communiqués
AGM Information Classification · 99% confidence The document is titled "MedinCell annonce les résultats de son Assemblée générale ordinaire annuelle et extraordinaire du 10 septembre 2020" (MedinCell announces the results of its Annual Ordinary and Extraordinary General Meeting of September 10, 2020). It explicitly details that the resolutions proposed at the General Meeting were adopted (or rejected) and mentions the approval of accounts and mandates. This content directly relates to the outcomes of a shareholder meeting. The most specific category for official results from shareholder votes at a general meeting is 'Declaration of Voting Results & Voting Rights Announcements' (DVA). Although it relates to an AGM, the focus is on the *results* of the vote, not the presentation materials (AGM-R) or the proxy solicitation (PSI). Given the explicit mention of voting results, DVA is the best fit.
2020-09-11 French
Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 95% confidence The document is titled "Information mensuelle relative au nombre d'actions composant le capital social et au nombre total des droits de vote" (Monthly information relating to the number of shares comprising the share capital and the total number of voting rights). It explicitly references Article 223-16 of the AMF General Regulation and provides a table detailing the total number of shares and voting rights as of July 31, 2020. This content directly relates to changes in share capital structure and voting rights, which aligns best with the 'Share Issue/Capital Change' (SHA) category, as it reports on the composition of the capital and voting rights, or potentially 'Major Shareholding Notification' (MRQ) if it were crossing a threshold, but the primary focus here is the monthly capital structure report. Given the options, reporting the total number of shares and voting rights monthly is a specific disclosure related to capital structure. However, none of the codes perfectly match a 'Monthly Capital Structure Report'. Let's re-evaluate the closest fit: 1. SHA (Share Issue/Capital Change): This covers changes in capital structure. Reporting the total count fits here. 2. MRQ (Major Shareholding Notification): This is for crossing ownership thresholds, which is not explicitly stated. 3. RNS (Regulatory Filings): This is a fallback. Since the document reports the total number of shares and voting rights, which is a fundamental aspect of the company's capital structure, SHA is the most appropriate classification among the provided specific codes, even though it's a recurring monthly report rather than a one-off change announcement. It is a mandatory disclosure related to the share capital base.
2020-08-03 French
Terms of availability of the preparatory documents for the GM
AGM Information Classification · 98% confidence The document explicitly discusses the 'Modalités de participation à l'Assemblée Générale Mixte' (Participation modalities for the Combined General Meeting) and provides details on how shareholders can vote remotely, including deadlines and procedures for proxy voting and internet voting (Votaccess). It also mentions the 'mise à disposition des documents préparatoires' (making preparatory documents available). This content is directly related to the logistics, procedures, and materials surrounding an Annual General Meeting (AGM). Although it mentions the availability of documents, the primary focus is on the meeting's procedures and voting rights, making AGM-R the most appropriate classification over RPA or LTR. The document is not the final voting results (DVA) nor the proxy solicitation material itself (PSI), but the announcement detailing how the AGM will proceed.
2020-07-31 French
Modalités de mise à disposition des documents préparatoires à l'AG
AGM Information Classification · 98% confidence The document explicitly discusses the 'Participation terms in the MedinCell Combined General Meeting' and details the procedures for voting and accessing preparatory documents for this meeting, scheduled for September 10, 2020. Key phrases include 'Annual General Meeting held in closed session', 'Voting procedures', and 'Availability of the documents for the General Meeting'. This content directly relates to the materials and announcements surrounding an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R (AGM Information). The document is an announcement providing details about the meeting logistics, not the final voting results (DVA) or a proxy solicitation statement (PSI), but rather the information package leading up to the AGM.
2020-07-31 English
Terms of availability of a registration document or its updates
Report Publication Announcement Classification · 98% confidence The document is a short announcement dated July 29, 2020, stating that MedinCell has filed its '2019/2020 Universal Registration Document (URD)' with the French market authority (AMF). The text explicitly mentions that this URD includes the annual financial report, management report, CSR report, and corporate governance report. Crucially, the document does not contain the full content of these reports but rather announces their availability and directs the reader to the company's website or the AMF's website to consult them. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report 'has been published' or is 'available' should be classified as a Report Publication Announcement (RPA). Although the content is substantial for a simple press release, its function here is purely to announce the publication of the URD/Annual Financial Report.
2020-07-29 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.